Search research articles
Contact Us
Filters
Showing results (81-90 of 99) with videos related to
Page
of 10
Sort By:
Microbiology (Reading, England)
|
April 27, 1999
Conversion of dTDP-4-keto-6-deoxyglucose to free dTDP-4-keto-rhamnose by the rmIC gene products of Escherichia coli and Mycobacterium tuberculosis
Richard J Stern, Tae-Yoon Lee, Tae-Jin Lee, et al.
BMJ Open
|
September 26, 2024
Interaction between economic status and healthy lifestyle in long COVID among Chinese older population: a cross-sectional study
Yaping Wang, Manchang Li, Bingkun Zhang, et al.
Research (Washington, D.C.)
|
September 20, 2024
Amino Turbo Chirality and Its Asymmetric Control
Ting Xu, Yu Wang, Shengzhou Jin, et al.
Journal of Ethnopharmacology
|
September 6, 2021
Screening tumor specificity targeted by arnicolide D, the active compound of Centipeda minima and molecular mechanism underlying by integrative pharmacology
Jingjing Yao, Qinghong Shen, Min Huang, et al.
Molecules (Basel, Switzerland)
|
May 25, 2024
C(sp)-C(sp) Lever-Based Targets of Orientational Chirality: Design and Asymmetric Synthesis
Ting Xu, Jia-Yin Wang, Yu Wang, et al.
Free Radical Biology & Medicine
|
April 18, 2024
TRPC4 aggravates hypoxic pulmonary hypertension by promoting pulmonary endothelial cell apoptosis
Liu Yang, Zeyu Peng, Fanpeng Gong, et al.
Journal of Medicinal Chemistry
|
December 7, 2023
Discovery of Highly Selective PARP7 Inhibitors with a Novel Scaffold for Cancer Immunotherapy
Hongfeng Gu, Wenxin Yan, Jieping Yang, et al.
Journal of Medicinal Chemistry
|
October 28, 2025
Discovery of Novel and Highly Potent Wee1 and HDAC Dual-Target Inhibitors for the Treatment of Acute Myeloid Leukemia
Wenhui Zhang, Wenxin Yan, Tianyi Wei, et al.
Journal of Medicinal Chemistry
|
December 28, 2022
Discovery of the Potent and Highly Selective PARP7 Inhibitor as a Novel Immunotherapeutic Agent for Tumors
Hongfeng Gu, Wenxin Yan, Yong Wang, et al.
Molecular Cancer Research : MCR
|
January 20, 2022
Tumor Microenvironment Acidity Triggers Lipid Accumulation in Liver Cancer via SCD1 Activation
Ming Ding, Shuwei Zhang, Yajuan Guo, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 99) with videos related to
Sort By:
Page
of 10
Microbiology (Reading, England)
|
April 27, 1999
Conversion of dTDP-4-keto-6-deoxyglucose to free dTDP-4-keto-rhamnose by the rmIC gene products of Escherichia coli and Mycobacterium tuberculosis
Richard J Stern, Tae-Yoon Lee, Tae-Jin Lee, et al.
BMJ Open
|
September 26, 2024
Interaction between economic status and healthy lifestyle in long COVID among Chinese older population: a cross-sectional study
Yaping Wang, Manchang Li, Bingkun Zhang, et al.
Research (Washington, D.C.)
|
September 20, 2024
Amino Turbo Chirality and Its Asymmetric Control
Ting Xu, Yu Wang, Shengzhou Jin, et al.
Journal of Ethnopharmacology
|
September 6, 2021
Screening tumor specificity targeted by arnicolide D, the active compound of Centipeda minima and molecular mechanism underlying by integrative pharmacology
Jingjing Yao, Qinghong Shen, Min Huang, et al.
Molecules (Basel, Switzerland)
|
May 25, 2024
C(sp)-C(sp) Lever-Based Targets of Orientational Chirality: Design and Asymmetric Synthesis
Ting Xu, Jia-Yin Wang, Yu Wang, et al.
Free Radical Biology & Medicine
|
April 18, 2024
TRPC4 aggravates hypoxic pulmonary hypertension by promoting pulmonary endothelial cell apoptosis
Liu Yang, Zeyu Peng, Fanpeng Gong, et al.
Journal of Medicinal Chemistry
|
December 7, 2023
Discovery of Highly Selective PARP7 Inhibitors with a Novel Scaffold for Cancer Immunotherapy
Hongfeng Gu, Wenxin Yan, Jieping Yang, et al.
Journal of Medicinal Chemistry
|
October 28, 2025
Discovery of Novel and Highly Potent Wee1 and HDAC Dual-Target Inhibitors for the Treatment of Acute Myeloid Leukemia
Wenhui Zhang, Wenxin Yan, Tianyi Wei, et al.
Journal of Medicinal Chemistry
|
December 28, 2022
Discovery of the Potent and Highly Selective PARP7 Inhibitor as a Novel Immunotherapeutic Agent for Tumors
Hongfeng Gu, Wenxin Yan, Yong Wang, et al.
Molecular Cancer Research : MCR
|
January 20, 2022
Tumor Microenvironment Acidity Triggers Lipid Accumulation in Liver Cancer via SCD1 Activation
Ming Ding, Shuwei Zhang, Yajuan Guo, et al.
Page
of 10